GE HealthCare price target lowered to $90 from $104 at Stifel

Stifel analyst Rick Wise lowered the firm’s price target on GE HealthCare (GEHC) to $90 from $104 and keeps a Buy rating on the shares. Despite tariff-related margin and EPS pressures, it is “clear” from the Q1 earnings call that the company’s “underlying business momentum continues to head in a positive direction,” the analyst tells investors. Encouraging for the company’s longer-term outlook, management highlighted that strong order growth performance is indicative of share gains across “a significant number of markets where we compete,” the analyst added.